NCT06656026View on ClinicalTrials.gov

Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

PHASE2RecruitingINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions

Influenza a

Interventions

DRUG

ZSP1273 granules

Oral

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital Of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY